PLEASANTON, Calif. – June 14, 2016 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, announced its sponsorship of the third annual “Drive for Men’s Health” event and presentation by urologist Dr. Carson Wong, chief of urology for University Hospitals Ahuja Medical Center, at the event’s stop at Anytime Fitness today in Cleveland, Ohio.
The Drive for Men’s Health is designed to increase awareness of men’s health issues and to encourage men to make their health a priority. During the “Drive,” Jamin Brahmbhatt, M.D., and Sijo Parekattil, M.D., co-directors of The PUR (Personalized Urology & Robotics) Clinic at South Lake Hospital, in affiliation with Orlando Health, will climb into an all-electric Tesla Model S and embark on a journey that will cover more than 6,000 miles, include more than 10 stops and feature hundreds of speakers, both at events along the way and online during the drive. The trip started in Florida on June 9, and headed north to New York and then west to Los Angeles, where the team will conduct its final stop on June 18.
“The Drive for Men’s Health, and the activities that Drs. Brahmbhatt and Parekattil undertake to raise awareness of men’s health issues, are incredibly important to everyone at NeoTract, which is why we are happy to be sponsoring this event for the third year in a row,” said Dave Amerson, president and CEO of NeoTract. “Benign prostatic hyperplasia, or BPH, is an incredibly common problem that impacts more than 80 percent of men by age 70; however often men assume the symptoms are standard signs of aging and don’t discuss them with their doctors. We want to change these conversations so men understand that BPH is a medical disorder that can be treated – not just an inevitable part of getting older.”
During the Tesla charging stops, the doctors will take part in educational lectures and activities designed to help men achieve and maintain their optimal health. As urologists, Dr. Brahmbhatt and Dr. Parekattil are uniquely qualified to lead discussion about men’s urological issues.
”We are thrilled to have NeoTract as a sponsor for this year's Drive for Men's Health event. UroLift provides a novel minimally invasive option for men suffering from an enlarged prostate with urination difficulties,” said Dr. Sijo Parekattil, urologic surgeon and co-founder of the PUR Clinic. “With these new advances in the field of urology they are making a difference in men's lives, which aligns perfectly with the focus of our Drive to raise awareness for men's health.”
BPH, also known as enlarged prostate, is a medical condition in which the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. The condition is common, affecting approximately 38 million men in the United States alone. BPH symptoms include sleepless nights and urinary problems, and can cause loss of productivity, depression and decreased quality of life.
NeoTract’s UroLift® System provides a unique approach to treating BPH that lifts and holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. UroLift is the only BPH procedure that does not require cutting, heating or removal of the prostate tissue.
Dr. Wong’s presentation on BPH and new treatment options, including the UroLift procedure, will take place at Anytime Fitness (11517 Clifton Blvd, Cleveland, OH 44102) from noon to 1:00 p.m. EDT.
“I’m very happy to have the opportunity to partner with NeoTract and the ‘Drive for Men’s Health’ to talk about BPH and help educate men about the various treatment options, including UroLift, so they understand the importance of discussing any relevant symptoms with their doctors,” said Dr. Wong. “I often find that my patients are concerned about potential side effects, so they decide to just deal with the symptoms rather than proceed with treatment. It is important to make sure they are aware of treatment options like UroLift, which has been proven effective in alleviating BPH symptoms without sexual side effects.”
To follow the doctors on their journey, support their efforts or to learn more about men’s health issues, log on to driveformenshealth.com.
About the UroLift System
The FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia and Canada.
NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. The company’s initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function. Learn more at www.UroLift.com or www.NeoTract.com.
For NeoTract, Inc.:
MAC00305-01 Rev A